NGN Capital

NGN Capital is a venture capital firm dedicated to healthcare investing, focusing on ventures with the potential to achieve above-average private equity returns with an emphasis on later-stage investments. The firm has the flexibility to invest in a broad cross-section of healthcare and biotechnology segments, including drug products, medical devices, and other healthcare services. NGN Capital is diversified by stage, from later-stage to selected early-stage opportunities, as well as by geography, investing predominantly in the United States, Europe, and Israel.

The firm is comprised of a professional team and advisors with exceptional investment and management backgrounds in healthcare and venture capital from leading institutions globally. NGN's professionals have been directly involved in transformational developments in healthcare that led to significant realizations for investors. NGN's advisors are recognized experts in their respective fields of healthcare, science, and corporate value creation and work actively with NGN's professionals. Collectively, NGN's professionals and advisors bring substantial value creation achievements and commercial expertise in healthcare ventures to the investments of NGN BioMed Opportunity I and NGN BioMed Opportunity II and their respective portfolio companies.

NGN Capital's North American office is in Stamford, Connecticut, and its European office is in Heidelberg, Germany. The firm's contact email is investorrelations@ngncapital.com, and the phone number is (212) 972-0077. The official website is https://www.ngncapital.com/.